Correction
Accepted on 29 Nov 2024
Corrigendum:Research progress of CD80 in the development of immunotherapy drugs
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1536312
Type at least 3 characters
6,683 articles
Articles
Editorial
Accepted on 29 Nov 2024
Editorial: Spotlighting the Interaction Network of Hub Genes, Molecules, and Cells in the Tumor Immune Microenvironment (TIME) and their Contribution to Malignant Progression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1533290
Review
Accepted on 29 Nov 2024
Targeting caspase-8: a new strategy for combating hepatocellular carcinoma Authors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1501659
Original Research
Accepted on 29 Nov 2024
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1500570
Original Research
Published on 29 Nov 2024
Single-cell RNA-seq reveals FGF12 as a prognostic biomarker in low-grade endometrial stromal sarcoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1513076
Review
Published on 29 Nov 2024
IL-17A in gastric carcinogenesis: good or bad?
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1501293
Original Research
Published on 29 Nov 2024
A novel anti-HER2 monoclonal antibody IAH0968 in HER2-positive heavily pretreated solid tumors: results from a phase Ia/Ib first-in-human, open-label, single center study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481326
- 119 views
Review
Published on 29 Nov 2024
Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1453753
Original Research
Published on 29 Nov 2024
Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1493673
- 100 views
Case Report
Published on 29 Nov 2024
Case report: Non-invasive cyto-salivary sampling and biomarker detection via ELISA versus histopathology for diagnosing oral potentially malignant disorders - Insights from a case-control study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477477
Review
Published on 29 Nov 2024
Unravelling the druggability and immunological roles of the SOCS-family proteins
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1449397
- 137 views
Original Research
Accepted on 28 Nov 2024
Leveraging Single-Cell and Multi-Omics Approaches to Identify MTOR-Centered Deubiquitination
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1490623
Original Research
Accepted on 28 Nov 2024
Effect of Immune Checkpoint Inhibitor Time-of-Day Infusion on Survival in Advanced Biliary Tract Cancer: A Propensity Score-Matched Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1512972
Review
Accepted on 28 Nov 2024
The Potential of Cellular Homing Behavior in Tumor Immunotherapy: From Basic Discoveries to Clinical Applications of Immune, Mesenchymal Stem, and Cancer Cell Homing
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495978
Original Research
Accepted on 28 Nov 2024
Prognostic Significance of Early Alpha Fetoprotein and Des-Gamma-Carboxy Prothrombin Responses in Unresectable Hepatocellular Carcinoma Patients Undergoing Triple Combination Therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1508028
Review
Accepted on 28 Nov 2024
Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1509195